Brief: Immunoscape Signs Deal With Cue Biopharma To Develop Solid Tumor Cancer Treatment

Cue Biopharma

13/11/2025 18:37

Nov 13 (Reuters) - ImmunoScape:

IMMUNOSCAPE: ENTERED IN-LICENSING DEAL WITH CUE BIOPHARMA FOR DEVELOPMENT OF NEW CLASS OF THERAPIES TO ATTACK SOLID TUMOR CANCERS

Source text: ID:nBw8LPGPFa

Further company coverage: AMGN.O

 ((Reuters.Briefs@thomsonreuters.com;))